Carrier design: New generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicity

Bioconjugate Chemistry

Volumn 10, Issue 5, 1999, Pages 781-790

  Hudecz, Ferenc ^a   Pimm, Malcolm V ^b   Rajnavölgyi, Éva ^c   Mezo, Gábor ^a   Fabra, Angels ^d   Gaál, Dezso ^e   Kovács, Attila L ^c   Horváth, Attila ^c   Szekerke, Mária ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d HOSPITAL DURAN I REYNALS   (Spain)

^e NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CHAINS; CYTOTOXICITY; MAMMALS; POLYPEPTIDES;

BIODISTRIBUTIONS; CARRIER DESIGN; DRUG-CONJUGATES; HYDROXYL GROUPS; IN-VITRO; MACROMOLECULE DRUGS; OH-GROUPS; POLYLYSINE; SIDE-CHAINS; VITRO CYTOTOXICITIES;

AMINO ACIDS;

EID: 0033200237     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990015q     Document Type: Article

References (37)

1. Duncan, R. (1992) Drug-polymer conjugates; potential for improved chemotherepy. Anti-Cancer Drugs 3, 153-156.
2. Maeda, H., Seymour, L. W., and Miyamoto, Y. (1992) Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate Chem. 3, 351-362.
3. Takakura, Y., and Hashida, M. (1995) Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs. Crit. Rev. Oncol./Haematol. 18, 207-231.
4. Del Giudice, G. (1992) New carriers and adjuvants in the development of vaccines. Curr. Opin. Immunol. 4, 454-459.
5. Hudecz, F., and Tóth, G. K. (1994) Synthetic peptide constructs to increase the immunogenicity of B-cell epitopes. In Synthetic peptides in the search for B- and T-cell epitopes (E. Rajnavölgyi, Ed.) pp 97-119, R. G. Landes Company, Austin.
6. Hudecz, F., Votavova, H., Gaál, D., Sponar, J., Kajtár, J., Blaha, K., and Szekerke, M. (1985) Branched polypeptides with a poly(L-lysine) backbone: synthesis, conformation and immunomodulation. In Polymeric Materials in Medication (Ch. G. Gebelein and Ch. E. Carraher, Eds.) pp 265-289, Plenum Press, New York.
7. Hudecz, F. (1995) Design of synthetic branched-chain polypeptides as carriers for bioactive molecules. Anti-Cancer Drugs 6, 171-193.
8. Clegg, J. A., Hudecz, F., Mezo, G., Pimm, M. V., Szekerke, M., and Baldwin, R. W. (1990) Carrier design: biodistribution of branched polypeptides with poly-(L-lysine) backbone. Bioconjugate Chem. 2, 425-430.
9. Hudecz, F., Gaál, D., Kurucz, I., Lányi, S., Kovács, A. L., Mezo, G., Rajnavölgyi, É., and Szekerke, M. (1992) Carrier design: cytotoxicity and immunogenicity of synthetic branched polypeptides with poly(L-lysine) backbone. J. Controlled Release 19, 231-243.
10. Hudecz, F., Hilbert, Á., Mezo, G., Kajtár, J., and Rajnavölgyi, E. (1994) B-cell epitopes in Herpes simplex Virus-(HSV-1) glycoprotein D (gD). In Synthetic peptides in the search for B- and T-cell epitopes (É. Rajnavölgyi, Ed.) pp 157-169, R. G. Landes Company, Austin.
11. Hudecz, F., and Price, M. R. (1992) Monoclonal antibody binding to peptide epitopes conjugated to synthetic branched polypeptide carriers. Influence of the carrier upon antibody recognition. J. Immunol. Methods 147, 201-210.
12. Wilkinson, K. A., Vordermeier, M. H., Wilkinson, R., Iványi, J., and Hudecz, F. (1998) Synthesis and in vitro T cell immunogenicity of conjugates with dual specificities: attachment of epitope peptides of 16 kDa and 38 kDa proteins from M.tuberculosis to branched polypeptide. Bioconjugate Chem. 9, 539-547.
13. Hudecz, F., Clegg, J. A., Kajtár, J., Embleton, M. J., Szekerke, M., and Baldwin, R. W. (1992) Synthesis, conformation, biodistribution and in vitro cytotoxicity of daunomycin-branched polypeptide conjugates. Bioconjugate Chem. 3, 49-57.
14. Gaál, D., and Hudecz, F. (1998) Low toxicity and high antitumour activity of daunomycin by conjugation to immunpotential amphoteric branched polypeptide. Eur. J. Cancer 34, 155-161.
15. Vincze, B., Pályi, I., Daubner, D., Kálnay, A., Mezo, G., Hudecz, F., Szekerke, M., Teplán, I., and Mezo, I. (1994) Antitumor effect of a GnRH antagonist and its conjugate on human breast cancer cells and their xenografts. J. Cancer Res. Clin. Oncol. 120, 578-584.
16. Mezo, G., Mezo, I., Seprodi, A., Teplán, I., Kovács, M., Vincze, B., Pályi, I., Kajtár, J., Szekerke, M., and Hudecz, F. (1996) Synthesis, conformation, biodistribution and hormon related in vitro antitumor effect of a GnRH antagonist-branched polypeptide conjugate. Bioconjugate Chem. 7, 642-650.
17. Hershfield, M. S., and Mitchell, B. S. (1995) In The Metabolic and Molecular bases of Inherited Disease (C. R. Scriver, A. L. Beaduet, W. S. Sly, and D. Valle, Eds.) pp 1725-1768, McGraw-Hill, New York.
18. Nucci, M. L., Shorr, R., and Abuchowski, A. (1991) The therapeutic values of poly(ethylene glycol)-modified proteins. Adv. Drug Deliv. Rev. 6, 133-151.
19. Mezo, G., Kajtár, J., Nagy, I., Majer, Zs., Szekerke, M., and Hudecz, F. (1997) Carrier design: Synthesis and conformational studies of poly[L-lysine] based branched polypeptides with hydroxyl groups. Biopolymers 42, 719-730.
20. Rose, K. (1994) Facile synthesis of homogeneous artificial proteins. J. Am. Chem. Soc. 116, 30-33.
21. Tuchscherer, G. (1993) Template assembled synthetic proteins. Tetrahedron Lett. 34, 8419-8430.
22. IUPAC-IUB Commission on Biochemical Nomenclature (1972) Biochem. J. 127, 753-756.
23. IUPAC-IUB Commission on Biochemical Nomenclature (1984) Eur. J. Biochem. 138, 9-37.
24. Hudecz, F., Kovács, P., Kutassi-Kovács, S., and Kajtár, J. (1984) GPC, CD and sedimentation analysis of poly-Lys and branched chain poly-Lys-poly-DL-Ala polypeptides. Colloid Polymer Sci. 262, 208-212.
25. Schippers, P. H., and Dekkers, H. P. J. (1981) Direct determination of absolute circular dichroism data and calibration of commercial instruments. Anal. Chem. 53, 778-782.
26. Greenfield, N., and Fasman, G. D. (1969) Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8, 4108-4116.
27. Seglen, P. O. (1976) Preparation of isolated rat liver cells. Methods Cell Biol. 13, 29-33.
28. Gaál, D., Hudecz, F., Kovács, A. L., and Szekerke, M. (1986) Immunomodulatory effect of synthetic branched polypeptides. II. J. Biol. Response Modif. 5, 148-159.
29. Scudiero, D. A., Shoemaker, R. H., and Paull, K. D., et al. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833.
30. 51Cr) for biodistribution studies and radiopharmaceutical development. J. Labelled Compd. Radiopharm. 36, 157-172.
31. 51Cr in mice. J. Controlled Release 37, 161-172.
32. Jerne, N. K., and Nordin, A. A. (1963) Plaque formation in agar by single anti-body-producing cells. Science 140, 405-409.
33. Behling, U. H., and Nowotny, A. (1978) Long-term adjuvant effect of bacterial endotoxin in prevention and restoration of radiation-caused immunosuppression. Proc. Soc. Exp. Biol. Med. 157, 348-353.
34. Arnold, L. J., Gutheil, I., and Kaplan, N. O. (1979) Antineoplastic activity of poly(l-lysine) with some ascites tumor cells. Proc. Natl. Acad. Sci U.S.A. 76, 3246-3250.
35. Votavova, H., Hudecz, F., Kajtár, J., Szekerke, M., Sponar, J., and Blaha, K. (1980) Conformation of branched polypeptides based on poly(L-lysine): circular dichroism study. Collect. Czech. Chem. Commun. 45, 941-949.
36. Hudecz, F., Kutassi-Kovács, S., Mezo, G., and Szekerke, M. (1989) Biodegradability of synthetic branched polypeptide with poly(L-lysine) backbone. Biol. Chem. Hoppe-Seyler 370, 1019-1026.
37. Rajnavölgyi, É., Hudecz, F., Mezo, G., Szekerke, M., and Gergely, J. (1986). Isotype distribution and fine specificity of the antibody response of inbred mouse strains to four compounds belonging to a new group of synthetic branched polypeptides. Mol. Immunol. 23, 27-37.